Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Hampson, Grace
Towse, Adrian
Pearson, Steven D
Dreitlein, William B
and
Henshall, Chris
2018.
Gene therapy: evidence, value and affordability in the US health care system.
Journal of Comparative Effectiveness Research,
Vol. 7,
Issue. 1,
p.
15.
de Folter, Joost
Trusheim, Mark
Jonsson, Pall
and
Garner, Sarah
2018.
DECISION-COMPONENTS OF NICE'S TECHNOLOGY APPRAISALS ASSESSMENT FRAMEWORK.
International Journal of Technology Assessment in Health Care,
Vol. 34,
Issue. 2,
p.
163.
Howard, Sarah
Scott, Ian A.
Ju, Hong
McQueen, Liam
and
Scuffham, Paul A.
2018.
Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
Australian Health Review,
Vol. 43,
Issue. 5,
p.
591.
Pichon-Riviere, Andres
Garcia-Marti, Sebastian
Oortwijn, Wija
Augustovski, Federico
and
Sampietro-Colom, Laura
2019.
Defining the Value of Health Technologies in Latin America: Developments in Value Frameworks to Inform the Allocation of Healthcare Resources.
International Journal of Technology Assessment in Health Care,
Vol. 35,
Issue. 1,
p.
64.
Booth, Neill
2019.
On value frameworks and opportunity costs in health technology assessment.
International Journal of Technology Assessment in Health Care,
Vol. 35,
Issue. 5,
p.
367.
Wurcel, Victoria
Cicchetti, Americo
Garrison, Louis
Kip, Michelle M.A.
Koffijberg, Hendrik
Kolbe, Anne
Leeflang, Mariska M.G.
Merlin, Tracy
Mestre-Ferrandiz, Jorge
Oortwijn, Wija
Oosterwijk, Cor
Tunis, Sean
and
Zamora, Bernarda
2019.
The Value of Diagnostic Information in Personalised Healthcare: A Comprehensive Concept to Facilitate Bringing This Technology into Healthcare Systems.
Public Health Genomics,
Vol. 22,
Issue. 1-2,
p.
8.
Pichon-Riviere, Andres
Garcia-Marti, Sebastian
Oortwijn, Wija
Augustovski, Federico
and
Sampietro-Colom, Laura
2019.
Definiendo el valor de las tecnologías sanitarias en Latino-América: desarrollo de marcos de valor para informar la priorización de recursos sanitarios.
International Journal of Technology Assessment in Health Care,
Vol. 35,
Issue. 1,
p.
69.
Korte, Brenda J.
Rompalo, Anne
Manabe, Yukari C.
and
Gaydos, Charlotte A.
2020.
Overcoming Challenges With the Adoption of Point-of-Care Testing.
Point of Care: The Journal of Near-Patient Testing & Technology,
Vol. 19,
Issue. 3,
p.
77.
Jakab, Ivett
Németh, Bertalan
Elezbawy, Baher
Karadayı, Melis Almula
Tozan, Hakan
Aydın, Sabahattin
Shen, Jie
and
Kaló, Zoltán
2020.
Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper Middle-Income Countries—A Systematic Literature Review on Value Frameworks and Multi-Criteria Decision Analyses.
Frontiers in Pharmacology,
Vol. 11,
Issue. ,
Sarri, Grammati
Freitag, Andreas
Szegvari, Boglarka
Mountian, Irina
Brixner, Diana
Bertelsen, Neil
Kaló, Zoltán
and
Upadhyaya, Sheela
2021.
The Role of Patient Experience in the Value Assessment of Complex Technologies – Do HTA Bodies Need to Reconsider How Value is Assessed?.
Health Policy,
Vol. 125,
Issue. 5,
p.
593.
Otero, Hansel J.
Miranda-Schaeubinger, Monica
and
Bresnahan, Brian W.
2022.
Evidence-Based Imaging in Pediatrics.
p.
1.
Pascal, Christophe
Mathy, Caryn
Bongiovanni, Isabelle
and
Konishi, Mario
2022.
Integrating organizational impacts into health technology assessment (HTA): an analysis of the content and use of existing evaluation frameworks.
International Journal of Technology Assessment in Health Care,
Vol. 38,
Issue. 1,
Wang, Ting
McAuslane, Neil
Goettsch, Wim G.
Leufkens, Hubert G. M.
and
De Bruin, Marie L.
2022.
Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile.
Frontiers in Pharmacology,
Vol. 13,
Issue. ,
Park, Jenny Yeonhee
Marcum, Zachary A.
and
Garrison, Louis P.
2022.
Toward a broader concept of societal value: family spillovers in Alzheimer's disease.
International Journal of Technology Assessment in Health Care,
Vol. 38,
Issue. 1,
Mathy, Caryn
Pascal, Christophe
Bongiovanni-Delarozière, Isabelle
and
Favez, Lauriane
2023.
Proposing a health-specific organizational impact framework to evaluate organizational impacts in health technology assessments.
International Journal of Technology Assessment in Health Care,
Vol. 39,
Issue. 1,
Krubiner, Carleigh B.
Tugendhaft, Aviva
DiStefano, Michael J.
Barsdorf, Nicola W.
Merritt, Maria W.
Goldstein, Susan J.
Mosam, Atiya
Potgieter, Sunita
Hofman, Karen J.
and
Faden, Ruth R.
2023.
The Value of Explicit, Deliberative, and Context-Specified Ethics Analysis for Health Technology Assessment: Evidence From a Novel Approach Piloted in South Africa.
Value in Health Regional Issues,
Vol. 34,
Issue. ,
p.
23.
Augustovski, Federico
Argento, Fernando
Alcaraz, Andrea
García Martí, Sebastián
Pichon Riviere, Andrés
and
Alfie, Verónica
2024.
Toward the Implementation of a Value Framework for Diagnostic Technologies: Operationalization, Piloting, and Validation in Latin America.
Value in Health,
Vol. 27,
Issue. 5,
p.
570.
Sánchez-Martínez, Fernando-Ignacio
Abellán-Perpiñán, José-María
Martínez-Pérez, Jorge-Eduardo
and
Gómez-Torres, Jorge-Luis
2024.
Design of a multiple criteria decision analysis framework for prioritizing high-impact health technologies in a regional health service.
International Journal of Technology Assessment in Health Care,
Vol. 40,
Issue. 1,
Main, Caitlin
Haig, Madeleine
Chavez, Danitza
and
Kanavos, Panos
2024.
Assessing the Value of Provider-Facing Digital Health Technologies Used in Chronic Disease Management: Toward a Value Framework Based on Multistakeholder Perceptions.
Medical Decision Making,
Vol. 44,
Issue. 1,
p.
28.
Gladkov, Natalie
2024.
Health Data Management.
p.
183.